Urinary L-FABP: A Novel Biomarker for Evaluating Diabetic Nephropathy Onset and Progression. A Narrative Review.
- Published in:
- Diabetes Therapy, 2025, v. 16, n. 6, p. 1107, doi. 10.1007/s13300-025-01731-w
- By:
- Publication type:
- Article
Works matching IS 18696953 AND DT 2025 AND VI 16 AND IP 6
Results: 14
1
2
Association of Blood Heavy Metals with Diabetic Foot Ulcers in U.S. Adults with Diabetes: Insights from the 1999–2004 NHANES Data.
- Published in:
- Diabetes Therapy, 2025, v. 16, n. 6, p. 1255, doi. 10.1007/s13300-025-01730-x
- By:
- Publication type:
- Article
3
Preferences, Expectations and Attitudes on Basal Insulin from Patient–Physician–Payer Perspective: A Multi-stakeholder Survey by the Italian Diabetes Society (ITA4P Study).
- Published in:
- Diabetes Therapy, 2025, v. 16, n. 6, p. 1241, doi. 10.1007/s13300-025-01729-4
- By:
- Publication type:
- Article
4
Efficacy and Safety of Tirzepatide Compared with GLP-1 RAs in Patients with Type 2 Diabetes Treated with Basal Insulin: A Network Meta-analysis.
- Published in:
- Diabetes Therapy, 2025, v. 16, n. 6, p. 1279, doi. 10.1007/s13300-025-01728-5
- By:
- Publication type:
- Article
5
Elevated Serum SERPINE2 Levels are Linked to Impaired Renal Function in Patients with Type 2 Diabetes Mellitus.
- Published in:
- Diabetes Therapy, 2025, v. 16, n. 6, p. 1313, doi. 10.1007/s13300-025-01742-7
- By:
- Publication type:
- Article
6
Advancing Cardiovascular, Kidney, and Metabolic Medicine: A Narrative Review of Insights and Innovations for the Future.
- Published in:
- Diabetes Therapy, 2025, v. 16, n. 6, p. 1155, doi. 10.1007/s13300-025-01738-3
- By:
- Publication type:
- Article
7
The Urgent Need for Breakthrough Therapies and a World Without Type 1 Diabetes.
- Published in:
- Diabetes Therapy, 2025, v. 16, n. 6, p. 1063, doi. 10.1007/s13300-025-01735-6
- By:
- Publication type:
- Article
8
Comprehending the Epidemiology and Aetiology of Childhood Obesity: Integrating Life Course Approaches for Prevention and Intervention.
- Published in:
- Diabetes Therapy, 2025, v. 16, n. 6, p. 1177, doi. 10.1007/s13300-025-01734-7
- By:
- Publication type:
- Article
9
Amylin: From Mode of Action to Future Clinical Potential in Diabetes and Obesity.
- Published in:
- Diabetes Therapy, 2025, v. 16, n. 6, p. 1207, doi. 10.1007/s13300-025-01733-8
- By:
- Publication type:
- Article
10
Cell Therapy for T1D Beyond BLA: Gearing Up Toward Clinical Practice.
- Published in:
- Diabetes Therapy, 2025, v. 16, n. 6, p. 1125, doi. 10.1007/s13300-025-01732-9
- By:
- Publication type:
- Article
11
The Association Between HbA1c Levels and the Risk of Myocardial Infarction and Stroke in People with Type 2 Diabetes: A Post Hoc Analysis of the REPRESENT Study.
- Published in:
- Diabetes Therapy, 2025, v. 16, n. 6, p. 1229, doi. 10.1007/s13300-025-01727-6
- By:
- Publication type:
- Article
12
Narrative Review: Continuous Glucose Monitoring (CGM) in Older Adults with Diabetes.
- Published in:
- Diabetes Therapy, 2025, v. 16, n. 6, p. 1139, doi. 10.1007/s13300-025-01720-z
- By:
- Publication type:
- Article
13
The Therapeutic Potential of Dipeptidyl Peptidase 4 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists in Diabetic Peripheral Neuropathy.
- Published in:
- Diabetes Therapy, 2025, v. 16, n. 6, p. 1077, doi. 10.1007/s13300-025-01712-z
- By:
- Publication type:
- Article
14
Lights and Shadows of Bariatric Surgery: Insights from a Nationwide Administrative Database of People Living with Type 1 Diabetes and Obesity.
- Published in:
- Diabetes Therapy, 2025, v. 16, n. 6, p. 1267, doi. 10.1007/s13300-025-01709-8
- By:
- Publication type:
- Article